4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
4DMedical, the global leader in cardiothoracic imaging software, announces that its latest imaging technology, CT:VQ™ has received CE Mark certification for commercial use in the European Union. 4DMedical will quickly launch commercial deployment of CT:VQ across one of the world’s largest respiratory imaging markets.
In a separate but concurrent announcement, 4DMedical has secured firm commitments from select institutional investors for an AU$83 million single-tranche private placement. This additional capital will support the Company’s growth strategy, particularly the expansion of CT:VQ™ in Europe.
